CORT Q1 2025 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$157M+7.1% YoY

Gross Profit

$155M98.5% margin

Operating Income

$3M2.2% margin

Net Income

$20M12.9% margin

EPS (Diluted)

$0.17

QoQ Revenue Growth

-13.6%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$5M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$846M

Total Liabilities

$163M

Stockholders' Equity

$683M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$157M	$147M	+7.1%
Gross Profit	$155M	$144M	+7.3%
Operating Income	$3M	$30M	-88.4%
Net Income	$20M	$28M	-26.9%